middle.news
Careteq takes R&D tax dispute to independent review
4:30pm on Friday 20th of November, 2026 AEDT
•
Healthcare Technology
Read Story
Careteq takes R&D tax dispute to independent review
4:30pm on Friday 20th of November, 2026 AEDT
Key Points
ATO rejects objections to amended assessments for FY2021, FY2022 and FY2023
Careteq disputes the decision and maintains its R&D activities were eligible
Company plans to apply to the Administrative Review Tribunal within weeks
Financial exposure and timing of a resolution remain undisclosed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Careteq (ASX:CTQ)
OPEN ARTICLE